Case Report
Successful Deep Inferior Epigastric Perforator Flap Harvest despite Preoperative Therapeutic Subcutaneous Heparin Administration into the Abdominal Pannus
Table 1
Table of clinical data.
| Patient | 1 | 2 | 3 |
| Age (years) | 55 | 33 | 37 | BMI (kg/m2) | 25 | 40 | 29 | Tumour Grade | III | III | II | Receptor status | ER+/HER2− | ER-/HER2− | ER+/HER2+ | Reason for anticoagulation | Axillary vein thrombosis | History of port-related thrombosis | Subclavian vein thrombosis | Time to thrombus | 6 weeks | NA | 4 weeks | Enoxaparin dose (mg) | 100 | 40 | 80 | Duration of anticoagulation | 3 months | 2 months | 4 months | Time LMWH stopped preoperatively (hours) | 32 h | 24 h (10 mg, 2 weeks earlier) | 32 h | Operation side | Unilateral | Bilateral | Unilateral | Lymph node surgery | Level II ANC | Level II ANC | SLNBx | Flap weight (grams) | 662 g | 794 g (L), 805 g (R) | 690 g | Perforators | Lateral row ×4 | Medial row ×1 (L), lateral row ×2 (R) | Medial row ×1 | Ischaemia time (mins) | 97 | 79 (L), 80 (R) | 26 | EBL from swab weights (mL) | 800 | 719 | 560 | Thromboprophylaxis | 40 mg enoxaparin | 5000 units of dalteparin | 5000 units of dalteparin | Total drain output (litres) | 2.7 L | 1.2 L | 1.2 L | Hospital stay | 7 days | 7 days | 6 days |
|
|
EBL: estimated blood loss. NA: not applicable. ANC: axillary node clearance. SLNBx: sentinel lymph node biopsy.
|